PRESS RELEASE The U.S. Food and Drug Administration today approved Dalvance (dalbavancin), a new antibacterial drug used to treat adults with skin infections. Dalvance is intended to treat acute bacterial...

PRESS RELEASE WASHINGTON, DC – May 19, 2014 – A series of research articles published ahead of print in the journal Antimicrobial Agents and Chemotherapy have identified a number of existing pharmaceutical...

A New Castle County, Delaware man is the first known infection with New Delhi metallo-beta-lactamase (NDM)–producing carbapenem-resistant Pseudomonas aeruginosa in the United States, according to...

NEWS RELEASE 30 APRIL 2014 | GENEVA – A new report by WHO–its first to look at antimicrobial resistance, including antibiotic resistance, globally–reveals that this serious threat is no longer...

In recent weeks there has been the release of a new product that suffocates head lice and a study by French and British researchers that show the effectiveness of an oral medication to treat head lice...

The World Health Organization (WHO) and the Ugandan Ministry of Health are unveiling a new drug to treat advanced sleeping sickness. The new drug is a combination of eflornithine and nifurtimox have been...

With the increase of multi-drug resistant infections happening all over the globe and the pronouncement by the World Health Organization (WHO) of antibiotic resistance as one of the top three greatest...